Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
DNA material
|
CS-RfA-EG (RDB04391)
,
pCMV-VSV-G-RSV-Rev (RDB04393)
,
pCAG-HIVgp (RDB04394)
|
81462
|
Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells.
|
Oncogene |
2020-5-1 |
Pubmed
Full text
|
C.elegans
|
tm3748
,
tm1429
|
80952
|
Tissue-specific silencing of integrated transgenes achieved through endogenous RNA interference in Caenorhabditis elegans.
|
RNA Biol |
2024-1-1 |
Pubmed
Full text
|
C.elegans
|
tm1200
,
tm1186
|
80909
|
Sensitized piRNA reporter identifies multiple RNA processing factors involved in piRNA-mediated gene silencing.
|
Genetics |
2023-8-9 |
Pubmed
Full text
|
C.elegans
|
tm3103
|
80881
|
Nucleus-independent transgenerational small RNA inheritance in Caenorhabditis elegans.
|
Sci Adv |
2023-10-27 |
Pubmed
Full text
|
C.elegans
|
tm1200
,
tm116
,
tm116102
|
80829
|
HRDE-2 drives small RNA specificity for the nuclear Argonaute protein HRDE-1.
|
Nat Commun |
2024-2-1 |
Pubmed
Full text
|
C.elegans
|
tm377
|
80793
|
Diversification of small RNA pathways underlies germline RNA interference incompetence in wild Caenorhabditis elegans strains.
|
Genetics |
2024-1-3 |
Pubmed
Full text
|
C.elegans
|
tm1200
|
80782
|
Condensate cooperativity underlies transgenerational gene silencing.
|
Cell Rep |
2023-8-29 |
Pubmed
Full text
|
C.elegans
|
tm1200
|
80740
|
A natural bacterial pathogen of C. elegans uses a small RNA to induce transgenerational inheritance of learned avoidance.
|
PLoS Genet |
2024-3-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HS-ES-1(RCB2364)
,
HS-ES-2M(RCB2360)
,
HS-ES-2R(RCB2361)
|
80711
|
Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers.
|
Nat Commun |
2024-6-5 |
Pubmed
Full text
|
Human and Animal Cells
|
MKN7
,
MKN45(RCB1001)
|
80037
|
Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
|
Ann Surg Oncol |
2013-3-1 |
Pubmed
Full text
|
Drosophila
|
D. pseudoobscura (k-s12),
,
D. eugracilis (E-18102),
,
D. mojavensis (k-s13)
|
78896
|
The absence of core piRNA biogenesis factors does not impact efficient transposon silencing in Drosophila
|
PLOS Biology |
2023-6-6 |
Pubmed
Full text
|
Human and Animal Cells
|
ACC-MESO-4(RCB2293)
,
Y-MESO-14(RCB5668)
|
78358
|
POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma.
|
Cancer Genomics Proteomics |
2024-1-1 |
Pubmed
Full text
|
DNA material
|
p3xFLAG-CMV14-FAM83H-FLAG (RDB20249)
|
78313
|
A novel mechanism of keratin cytoskeleton organization through casein kinase Iα and FAM83H in colorectal cancer.
|
J Cell Sci |
2013-10-15 |
Pubmed
Full text
|
Human and Animal Cells
|
T98G(RCB1954)
,
U251(RCB0461)
|
77690
|
Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients.
|
Oncol Rep |
2006-6-1 |
Pubmed
|
Zebrafish
|
UAS:GFP
|
77279
|
UBTOR/KIAA1024 regulates neurite outgrowth and neoplasia through mTOR signaling.
|
PLoS Genet |
2018-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
MKN45(RCB1001)
|
77170
|
Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line.
|
Invest New Drugs |
2013-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PANC-1(RCB2095)
|
77133
|
Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
|
Oncol Rep |
2011-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
COLO-320(RCB1193)
,
LoVo(RCB1639)
|
77042
|
Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
|
Cancer Sci |
2021-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
MKN28(RCB1000)
|
77018
|
Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A.
|
Oncotarget |
2016-2-9 |
Pubmed
Full text
|
Human and Animal Cells
|
OS-RC-2(RCB0735)
|
76469
|
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer.
|
Clin Cancer Res |
2018-12-15 |
Pubmed
Full text
|